We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+9.52%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$635B
AUM Growth
+$46.7B
Cap. Flow
+$6.91B
Cap. Flow %
1.09%
Top 10 Hldgs %
21.34%
Holding
3,874
New
120
Increased
1,999
Reduced
1,571
Closed
91

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$939M
2
NVDA icon
NVIDIA
NVDA
+$796M
3
ABT icon
Abbott
ABT
+$619M
4
AAPL icon
Apple
AAPL
+$588M
5
TXN icon
Texas Instruments
TXN
+$463M

Top Sells

Rank Stock Value
1
HEI.A icon
HEICO Corp Class A
HEI.A
+$1.46B
2
AMZN icon
Amazon
AMZN
+$725M
3
FERG icon
Ferguson
FERG
+$619M
4
KDP icon
Keurig Dr Pepper
KDP
+$445M
5
ISRG icon
Intuitive Surgical
ISRG
+$434M

Sector Composition

Rank Sector Weight
1 Technology 27.87%
2 Financials 12.45%
3 Industrials 11.55%
4 Consumer Discretionary 9.95%
5 Healthcare 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATXS
3601
DELISTED
Astria Therapeutics
ATXS
$117K ﹤0.01%
16,073
+911
+6% +$6.17K
NOTV
3602
DELISTED
Inotiv
NOTV
$115K ﹤0.01%
79,450
+2,867
+4% +$5.12K
ALTO icon
3603
Alto Ingredients
ALTO
$342M
$114K ﹤0.01%
105,975
-108,767
-51% -$122K
FENC icon
3604
Fennec Pharmaceuticals
FENC
$351M
$114K ﹤0.01%
12,127
+767
+7% +$6.64K
MXCT icon
3605
MaxCyte
MXCT
$114M
$113K ﹤0.01%
71,670
+21,049
+42% +$36.6K
MATH icon
3606
Metalpha Technology Holding
MATH
$42.4M
$112K ﹤0.01%
+30,527
New +$101K
CURI icon
3607
CuriosityStream
CURI
$148M
$112K ﹤0.01%
21,071
+42
+0.2% +$193
PLTK icon
3608
Playtika
PLTK
$1.51B
$111K ﹤0.01%
28,595
+1,781
+7% +$7.27K
EPSM
3609
Epsium Enterprise
EPSM
$18.4M
$111K ﹤0.01%
+10,380
New +$263K
DSGN icon
3610
Design Therapeutics
DSGN
$743M
$110K ﹤0.01%
14,589
+225
+2% +$1.13K
TARA icon
3611
Protara Therapeutics
TARA
$223M
$109K ﹤0.01%
25,169
+1,234
+5% +$4K
LILA icon
3612
Liberty Latin America Class A
LILA
$1.66B
$107K ﹤0.01%
19,048
+988
+5% +$4.94K
SDA icon
3613
SunCar Technology Group
SDA
$80.5M
$107K ﹤0.01%
43,265
-704
-2% -$1.72K
VIOT
3614
Viomi Technology
VIOT
$50.8M
$107K ﹤0.01%
+31,927
New +$105K
PAYS icon
3615
Paysign
PAYS
$513M
$106K ﹤0.01%
16,875
-67
-0.4% -$428
HSHP
3616
Himalaya Shipping
HSHP
$718M
$106K ﹤0.01%
12,848
+1,253
+11% +$9.37K
PSNY icon
3617
Polestar Automotive Holding UK
PSNY
$2.09B
$105K ﹤0.01%
3,730
-635
-15% -$20.3K
FIRY
3618
Firy Inc
FIRY
$161M
$103K ﹤0.01%
12,896
-13,239
-51% -$102K
ASUR icon
3619
Asure Software
ASUR
$235M
$103K ﹤0.01%
12,531
+1,044
+9% +$9.33K
LFCR icon
3620
Lifecore Biomedical
LFCR
$167M
$100K ﹤0.01%
13,603
-365,810
-96% -$2.77M
PLX icon
3621
Protalix BioTherapeutics
PLX
$189M
$99.9K ﹤0.01%
45,003
-138
-0.3% -$225
SRG
3622
Seritage Growth Properties
SRG
$130M
$99.6K ﹤0.01%
23,438
+3,891
+20% +$13.6K
RDNW
3623
RideNow Group
RDNW
$251M
$99K ﹤0.01%
22,500
-23,087
-51% -$73.7K
DMAC icon
3624
DiaMedica Therapeutics
DMAC
$365M
$98.5K ﹤0.01%
14,335
+450
+3% +$2.44K
CAPR icon
3625
Capricor Therapeutics
CAPR
$338M
$98.5K ﹤0.01%
13,655
-869
-6% -$6.4K

Similar funds

Invesco's Q3 2025 Portfolio in Review

As of Q3 2025, Invesco held 3,874 positions worth $635B, up 7.9% from $588B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Invesco's Q3 2025 filing shows 120 new, 1,999 increased, 1,571 reduced and 91 closed positions. Its largest new stake was Paramount Skydance Corp: 15,251,112 shares worth $289M. The largest sale was HEICO Corp Class A, an estimated $1.46B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

  • Invesco's largest Q3 2025 buy was Paramount Skydance Corp: 15,251,112 shares worth $289M.
  • Invesco added most to Microsoft in Q3 2025, an estimated $939M increase.
  • Invesco's biggest Q3 2025 reduction was HEICO Corp Class A, cutting an estimated $1.46B.
  • Invesco fully exited Hess in Q3 2025, selling an estimated $401M.
  • Invesco's ten largest holdings make up 21% of its $635B portfolio in Q3 2025.
  • Invesco opened 120 new positions and closed 91 in Q3 2025.
  • Invesco's portfolio value rose 7.9% quarter-over-quarter to $635B.

Based on Invesco's 13F filing for Q3 2025, filed 13 Nov 2025.